Zychma, Marcin
Novo Nordisk (Denmark)
2 papers on CoChat
Most cited papers
- Verified
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 1,503
- Verified
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets
DeVries, J. H., Bain, S. C., Rodbard, H. W., Seufert, J., D’Alessio, D., Thomsen, A. B., Zychma, M., Rosenstock, J., & on behalf of the Liraglutide-Detemir Study Group (2012) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 159
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free